Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Research Tools and Instruments - Category 1 (<$150,000)

University of Alberta

$87,000.00

A small animal imager for drug delivery and tissue engineering research

EF 2010-11

Résumé
Probing the mechanism of action and improving the performance of therapeutic agents in animals are indispensable parts of developing new and innovative therapeutic interventions. Evaluating the performance of therapeutic agents in small animals is ideal in an academic setting since it is cost effective and provides an optimal system before large animal testing in an industrial setting. Small animal testing, however, is labour intensive. It usually requires large number of animals since the conventional approach is to recover the therapeutic agents at the end of a study period and investigate their action after a given period of time. Recent technologies advances have created small animal imagers where molecular, cellular and tissue-level information could be effectively obtained based on light-emitting probes. This new approach is beginning to allow us to probe the mechanisms of action of therapeutic agents in situ without the need to sacrifice the animal for the retrieval of such agents. It is allowing researchers to rapidly engineer therapeutic agents and optimize their performance in a short period of time. This project is intended to acquire a state-of-the-art instrument for this purpose. This instrument will enhance our research capability by providing valuable information about our therapeutic approaches, and expedite our research activity by making a vital tool available continually for our research. It will lead to reduced use of animals in research and provide a more comprehensive evaluation of therapeutic agents intended for human use.
Programme
Research Tools and Instruments - Category 1 (<$150,000)
Bénéficiaire
Emplacement
Alberta, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data

Tel que publié

Application id
406289-2011
Name nom
Uludag, Hasan
Department département
Chemical and Materials Engineering
Organization id
9
Institution établissement
University of Alberta
Province en
Alberta
Province fr
Alberta
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2010
Competition year année de concours
2011
Award amount
87000
Program id
EQPEQ
Program name en
Research Tools and Instruments - Category 1 (<$150,000)
Program name fr
Outils et instruments de recherche - catégorie 1 (<150 000$)
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
1511
Committee name en
Materials and Chemical Engineering
Committee name fr
Génie chimique et des matériaux
Area of application code
504
Area of application group en
Manufacturing processes and products
Area of application group fr
Procédés et produits industriels
Area of application en
Human pharmaceuticals
Area of application fr
Produits pharmaceutiques administrables à l'homme
Research subject code
1902
Research subject group en
Biomedical engineering
Research subject group fr
Génie biomédical
Research subject en
Biomedical materials
Research subject fr
Matériaux biomédicaux
Partie
1
Nb partie
1
Application title
A small animal imager for drug delivery and tissue engineering research
Keyword
NSERC
Application summary
Probing the mechanism of action and improving the performance of therapeutic agents in animals are indispensable parts of developing new and innovative therapeutic interventions. Evaluating the performance of therapeutic agents in small animals is ideal in an academic setting since it is cost effective and provides an optimal system before large animal testing in an industrial setting. Small animal testing, however, is labour intensive. It usually requires large number of animals since the conventional approach is to recover the therapeutic agents at the end of a study period and investigate their action after a given period of time. Recent technologies advances have created small animal imagers where molecular, cellular and tissue-level information could be effectively obtained based on light-emitting probes. This new approach is beginning to allow us to probe the mechanisms of action of therapeutic agents in situ without the need to sacrifice the animal for the retrieval of such agents. It is allowing researchers to rapidly engineer therapeutic agents and optimize their performance in a short period of time. This project is intended to acquire a state-of-the-art instrument for this purpose. This instrument will enhance our research capability by providing valuable information about our therapeutic approaches, and expedite our research activity by making a vital tool available continually for our research. It will lead to reduced use of animals in research and provide a more comprehensive evaluation of therapeutic agents intended for human use.